IMPACT OF TYROSINE KINASE INHIBITORS ON MINIMAL RESIDUAL DISEASE AND OUTCOME IN CHILDHOOD PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA

BACKGROUND: BCR-ABL1 tyrosine kinase inhibitors (TKIs) improve the outcome of childhood Philadelphia-chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) when incorporated into post-remission induction chemotherapy. No data is available on the impact of TKIs on end of induction minimal residua...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer
Päätekijät: Jeha, Sima, Coustan-Smith, Elaine, Pei, Deqing, Sandlund, John T., Rubnitz, Jeffrey E., Howard, Scott C., Inaba, Hiroto, Bhojwani, Deepa, Metzger, Monika L., Cheng, Cheng, Choi, John K., Jacobsen, Jeffrey, Shurtleff, Sheila A., Raimondi, Susana, Ribeiro, Raul C., Pui, Ching-Hon, Campana, Dario
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2014
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4249731/
https://ncbi.nlm.nih.gov/pubmed/24501014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28598
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia